Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-25,888
Closed -$1.91M 146
2023
Q2
$1.91M Buy
25,888
+1,172
+5% +$89.3K 0.09% 286
2023
Q1
$1.95M Buy
24,716
+510
+2% +$36.8K 0.08% 279
2022
Q4
$1.65M Buy
+24,206
New +$1.54M 0.06% 321
2022
Q3
Sell
-18,685
Closed -$1.17M 1567
2022
Q2
$1.17M Buy
+18,685
New +$1.15M 0.04% 477
2021
Q3
Sell
-17,302
Closed -$1.31M 1241
2021
Q2
$1.31M Buy
+17,302
New +$1.21M 0.03% 441
2021
Q1
Sell
-33,200
Closed -$1.8M 816
2020
Q4
$1.8M Buy
33,200
+17,700
+114% +$849K 0.06% 263
2020
Q3
$616K Buy
+15,500
New +$646K 0.08% 194

Other funds holding BRKR

Ergoteles's BRKR Position: Q3 2023 in Review

Ergoteles sold out of Bruker (BRKR) in Q3 2023, closing a stake of 25,888 shares — an estimated $1.91M sold.

Ergoteles first reported a position in BRKR in Q3 2020 and held it in 7 quarters. The position peaked at $1.95M in Q1 2023. 345 funds tracked by Wall St. Rank hold BRKR as of Q3 2023.

  • Ergoteles reported no remaining Bruker position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 25,888 Bruker shares in Q3 2023, an estimated $1.91M.
  • Ergoteles first reported a position in Bruker in Q3 2020 and held it in 7 quarters.
  • Ergoteles's Bruker position peaked at $1.95M in Q1 2023.
  • 345 funds tracked by Wall St. Rank held Bruker as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.